Advertisement
Screener

TAURUS ASSET MANAGEMENT, LLC Historic Quarter Change: Foreign Stocks, Reduced

TAURUS ASSET MANAGEMENT, LLC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 18 quarters from 2013-06-30 to 2025-03-31, TAURUS ASSET MANAGEMENT, LLC opened 1 positions, added to 1, reduced 20 and sold out of 2.

  • Q3 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 21,550.
  • Q3 2016: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 14,025.
  • Q2 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 21,750.
  • Q1 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 21,950.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1317209), 18 quarters: Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-13); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-13); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-07); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-08); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016NVS
NOVARTIS A G
SPONSORED ADR21,55020,300-1,250$1,778,000$1,603,000-$175,0002016-11-14
Q3 2016DEO
DIAGEO P L C
SPON ADR NEW14,02513,625-400$1,583,000$1,581,000-$2,0002016-11-14
Q2 2016NVS
NOVARTIS A G
SPONSORED ADR21,75021,550-200$1,576,000$1,778,000+$202,0002016-08-15
Q1 2016NVS
NOVARTIS A G
SPONSORED ADR21,95021,750-200$1,889,000$1,576,000-$313,0002016-05-16
Q4 2015DEO
DIAGEO P L C
SPON ADR NEW14,42514,025-400$1,555,000$1,530,000-$25,0002016-02-16
Q3 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR9,0936,193-2,900$537,000$350,000-$187,0002015-11-16
Q3 2015NVS
NOVARTIS A G
SPONSORED ADR22,05021,950-100$2,168,000$2,018,000-$150,0002015-11-16
Q2 2015DEO
DIAGEO P L C
SPON ADR NEW14,62514,425-200$1,617,000$1,674,000+$57,0002015-08-14
Q2 2015NVS
NOVARTIS A G
SPONSORED ADR22,10022,050-50$2,179,000$2,168,000-$11,0002015-08-14
Q1 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR9,1539,093-60$526,000$566,000+$40,0002015-05-15
Q4 2014NVS
NOVARTIS A G
SPONSORED ADR22,60022,100-500$2,127,000$2,048,000-$79,0002015-02-17
Q3 2014DEO
DIAGEO P L C
SPON ADR NEW14,92514,625-300$1,900,000$1,688,000-$212,0002014-11-14
Q3 2014NVS
NOVARTIS A G
SPONSORED ADR22,80022,600-200$2,064,000$2,127,000+$63,0002014-11-14
Q2 2014NVS
NOVARTIS A G
SPONSORED ADR23,08022,800-280$1,962,000$2,064,000+$102,0002014-08-14
Q2 2014DEO
DIAGEO P L C
SPON ADR NEW15,17514,925-250$1,891,000$1,900,000+$9,0002014-08-14
Q1 2014DEO
DIAGEO P L C
SPON ADR NEW17,16515,175-1,990$2,273,000$1,891,000-$382,0002014-05-15
Q4 2013DEO
DIAGEO P L C
SPON ADR NEW17,57517,165-410$2,233,000$2,273,000+$40,0002014-02-14
Q4 2013NVS
NOVARTIS A G
SPONSORED ADR24,22523,080-1,145$1,858,000$1,855,000-$3,0002014-02-14
Q3 2013NVS
NOVARTIS A G
SPONSORED ADR63,35024,225-39,125$4,479,000$1,858,000-$2,621,0002013-11-14
Q3 2013DEO
DIAGEO P L C
SPON ADR NEW18,37517,575-800$2,112,000$2,233,000+$121,0002013-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet